More ways, to save more lives, for less money: World Health Assembly adopts more Best Buys to tackle noncommunicable diseases
More ways, to save more lives, for less money: World Health Assembly adopts more Best Buys to tackle noncommunicable diseases The World Health Organization has expanded the list of ‘NCD…
WHO urges governments to stop subsidizing life-threatening tobacco crops
WHO urges governments to stop subsidizing life-threatening tobacco crops On World No Tobacco Day, WHO urges governments to stop subsidizing tobacco farming and support more sustainable crops that could feed millions.…
Bolivia conducts a simulation exercise to strengthen the National Deployment and Vaccination Plan for influenza and other respiratory viruses
Bolivia conducts a simulation exercise to strengthen the National Deployment and Vaccination Plan for influenza and other respiratory viruses As part of a series of twelve workshops to identify lessons…
Ultomiris approved in Japan for the prevention of relapses in patients with neuromyelitis optica spectrum disorder (NMOSD)
Ultomiris approved in Japan for the prevention of relapses in patients with neuromyelitis optica spectrum disorder (NMOSD) Ultomiris (ravulizumab) has been approved in Japan as the first and only long-acting C5…
Imfinzi plus Lynparza and Imfinzi alone both significantly improved progression-free survival in advanced endometrial cancer when added to chemotherapy
Imfinzi plus Lynparza and Imfinzi alone both significantly improved progression-free survival in advanced endometrial cancer when added to chemotherapy Positive high-level results from the DUO-E Phase III trial showed Imfinzi (durvalumab) in…
AstraZeneca will highlight momentum of practice-changing cancer medicines across its robust pipeline at ASCO 2023
AstraZeneca will highlight momentum of practice-changing cancer medicines across its robust pipeline at ASCO 2023 AstraZeneca advances its ambition to revolutionise cancer care with new data across its industry-leading portfolio…
Pfizer’s PAXLOVID™ receives FDA approval for adult patients at high risk of progression to severe COVID-19
Pfizer’s PAXLOVID™ receives FDA approval for adult patients at high risk of progression to severe COVID-19 Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA)…
Multivitamin improves memory in older adults, study finds
Multivitamin improves memory in older adults, study finds Taking a daily multivitamin supplement can slow age-related memory decline, finds a large study led by researchers at Columbia University and Brigham…
Capturing transporter structure paves the way for drug development
Capturing transporter structure paves the way for drug development Scientists at St. Jude Children’s Research Hospital and the University of Texas Southwestern Medical Center studied the structure and function of…
EUROPEAN STUDY FINDS THE ABBOTT CARDIOMEMS SENSOR RESULTS IN IMPROVED QUALITY OF LIFE AND 44% REDUCTION IN HEART FAILURE HOSPITALIZATIONS
EUROPEAN STUDY FINDS THE ABBOTT CARDIOMEMS SENSOR RESULTS IN IMPROVED QUALITY OF LIFE AND 44% REDUCTION IN HEART FAILURE HOSPITALIZATIONS New data presented from an investigator-sponsored European trial found managing…
Lilly ESG Report Highlights Progress Towards Sustainability Goals
Lilly ESG Report Highlights Progress Towards Sustainability Goals Eli Lilly and Company (NYSE: LLY) today released its latest Environmental, Social and Governance (ESG) report showing progress towards the company’s ambitious sustainability goals, which…
Teva to Present Data
Teva to Present Data Demonstrating UZEDY™ (risperidone) Extended-Release Injectable Suspension Significantly Prolonged Time to Impending Relapse for Adults with Schizophrenia at the American Psychiatric Association’s 2023 Annual Meeting Teva Pharmaceuticals,…